Following GMP certification in China, Colombia, Brazil, Argentina, Egypt, Indonesia and Pakistan, Kexing BioPharm, the global licensee for bevacizumab injection in emerging markets, has initiated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback